Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 237   

Articles published

SNY 47.15 +0.58 (1.25%)
price chart
Sanofi SA's (SNY) Oral Gaucher Disease Drug Backed By European CHMP
Sanofi SA (ADR)'s (NYSE:SNY) subsidiary Genzyme announced Friday that its drug Cerdelga has won the positive recommendation of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) as a treatment for type ...
Related articles »  
Sanofi SA (SNY), Regeneron Pharmaceuticals (REGN) Eczema Drug Gets FDA ...
Sanofi SA (ADR) (NYSE:SNY) and its US-based partner Regeneron Pharmaceuticals Inc's (NASDAQ:REGN) jointly developed experimental drug dupilumab has been granted breakthrough therapy designation by the US Food and Drug Administration for use ...
Related articles »  
Sanofi (SNY) Expects $37.6 Billion Revenues From New Drugs
Sanofi SA (ADR) (NYSE:SNY), which has recently been in the limelight for the much publicized ousting of its former CEO Christopher Viehbacher, expressed confidence in its drug pipeline in a statement today.
Related articles »  
Sanofi SA (SNY) Stock On A Decline Since Ousting Of CEO Chris Viehbacher
Shares of Sanofi SA (ADR) (SNY) continue their downward journey since Chris Viehbacher was ousted from his position as CEO late October by the company's board of directors in the coup led by Chairman Serge Weinberg.
Related articles »  
Sanofi Fires CEO Following Clash With Board
Sanofi SA (ADR) (SNY) announced today that the company's board has decided to oust Chief Executive Officer Christopher Viehbacher, finally putting the rumors to rest.
Related articles »  
Price Losers - Tyson Foods, Inc. (NYSE:TSN), Sanofi SA (ADR) (NYSE:SNY ...
Houston, TX - Nov21, 2014 - (Techsonian) �Tyson Foods, Inc. (NYSE:TSN)Announced that executives told investors at the Morgan Stanley Global Consumer and Retail Conference that the company had a record year in fiscal 2014 and expects fiscal 2015 to ...
Related articles »  
Moving Stocks: Sanofi SA (ADR) (NYSE:SNY), Kinder Morgan Energy Partners ...
Sanofi SA (ADR) (NYSE:SNY), which has recently been in the limelight for the much publicized ousting of its former CEO Christopher Viehbacher, expressed confidence in its drug pipeline in a statement today.
4 Red-Hot Healthcare Stocks: Sanofi SA (ADR) (NYSE:SNY), Salix ...
Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) made noteworthy gains on Tuesday after reporting positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with ...
Related articles »  
Hot Stocks: General Motors Company (GM), Sanofi SA (ADR) (SNY), Royal Bank ...
Sanofi SA (ADR) (NYSE:SNY) has briefed about its pipeline products and said that as much as 18 new drugs could be rolled out by the year 2020.
Best Stocks: Vipshop Holdings Limited (NYSE:VIPS), Sanofi SA (ADR) (NYSE ...  Property Mentor
Healthcare Stocks Buzz- Sanofi, (NYSE:SNY), Pfizer, (NYSE:PFE), Merck & ...  Techsonian (press release)
Related articles »  
Buzz Stocks: Orbital Sciences Corp, Sanofi SA (ADR), and American Realty ...
Futures are little changed this morning, as investors await this afternoon's policy statement from the Federal Open Market Committee (FOMC).
Dark Clouds Hover Over Sanofi SA (ADR) (NYSE:SNY) and Twitter Inc (NYSE ...  Markets Emerging
Healthcare Stocks with Major Changes- Sanofi SA (ADR) (NYSE:SNY), Eli Lilly ...  StreetWise Report
Related articles »